RE:RE:RE:Best of luck hope agn gets nasdaq and goes to $20 What's simple to understand is the current market cap is a paltry figure compared to current analysts who cover Nasdaq stocks. Algernon will be one of only a few companies with DMT in human clinical trials come January 2022. See GH Research regarding its DMT program in Phase 2 human clinical trial. Nasdaq analysts place a market cap valuation north of 3 Billion $ CAD. GH Research current market cap is 1.6 Billion CAD.
Algernon also has a stand-alone Chronic Cough human clinical trial starting this year. There's only one other company currently at Phase 2 for Chronic Cough. Bellus Health has been talked up by Algernon as a comparison for a longtime now. The analysts who cover Nasdaq stocks place a market cap valuation north of 1 Billion CAD. Bellus Health current market cap is 560 Million $ CAD.
The above numbers are not fiction. It's facts and Algernon falls among those companies chasing after treatments with their respective lead drug candidates. Somehow, people on the CSE and OTC fail to see a picture bigger than anything trading around pennies. It's the primary reason Algernon is moving to the Nasdaq. It's there where Algernon's current value will be unlocked and unchained from those who don't understand a thing about biotech companies and their progressive value.
I'm not here to arh=gue with anyone about hown Algernon should be valued by investors who don't understand business 101. Let alone how to see the pending trajectory of the stock price once listed on Nasdaq. The overall narrative will be out of the hands of the likes of those who exclusively trade penny stocks on the CSE and OTC. Those type of investors live in a small world and think in terms of small gains. Somebody gotta make a killing on investments and anyone following the real story about Algernon's chances knows the current market cap is absurdly ridiculous compared to any biotech company that trades on any exchange.
Algernon is long past due to turn the page on the bottom feeder penny stock market and start swimming with the real sharks and whales in the biotech world.